PCRX
HealthcarePacira BioSciences, Inc.
$23.18-0.34 (-1.47%)
Prev Close
$23.53
Open
$23.30
High
$23.65
Low
$23.04
Volume
464.2K
Market Cap
$952.7M
P/E
154.57
Div Yield
—
Over the past 12 months, insider activity at Pacira BioSciences, Inc. (PCRX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 12 insider sales totaling $2.76M. The most recent insider transaction was by RIKER LAUREN (officer: Senior Vice President, Finance), who sold $83.2K worth of shares on Feb 3, 2026. Pacira BioSciences, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $952.7M.
Buys (12M)
0
$0.00
Sells (12M)
12
$2.76M
Net Activity
Net Seller
$2.76M
Active Insiders
7
last 12 mo
PCRX Price Chart
PCRX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026↗ | RIKER LAUREN | officer: Senior Vice President, Finance | Sell | 4,000 | $20.81 | $83.2K | 52,313.2 |
| Feb 3, 2026↗ | WILLIAMS KRISTEN | officer: Chief Administrative Officer | Sell | 13,137 | $20.53 | $269.7K | 131,303 |
| Jan 30, 2026↗ | Teehan Brendan | Chief Commercial Officer | Sell | 5,182 | $20.54 | $106.4K | 0 |
| Jan 30, 2026↗ | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 30,271 | $20.54 | $621.6K | 0 |
| Jan 6, 2026↗ | RIKER LAUREN | officer: Senior Vice President, Finance | Sell | 1,416 | $24.24 | $34.3K | 59,064.2 |
| Jan 2, 2026↗ | Lee Frank D. | Chief Executive Officer | Sell | 9,272 | $24.46 | $226.8K | 0 |
| Jan 2, 2026↗ | RIKER LAUREN | Senior Vice President, Finance | Sell | 1,575 | $24.26 | $38.2K | 0 |
| Dec 9, 2025↗ | Cross Shawn | Chief Financial Officer | Sell | 25,000 | $25.07 | $626.8K | 0 |
| Nov 10, 2025↗ | Cross Shawn | Chief Financial Officer | Sell | 12,060 | $22.09 | $266.4K | 0 |
| Aug 7, 2025↗ | BIGAL MARCELO | Director | Sell | 4,912 | $23.67 | $116.3K | 0 |
| Jun 3, 2025↗ | RIKER LAUREN | Senior Vice President, Finance | Sell | 8,952 | $26.28 | $235.3K | 0 |
| Jun 3, 2025↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 5,084 | $26.40 | $134.2K | 0 |
| Jan 6, 2025↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 879 | $18.40 | $16.2K | 93,443.5 |
| Dec 16, 2024↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 500 | $19.76 | $9.9K | 115,200 |
| Sep 13, 2024↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 500 | $12.86 | $6.4K | 115,700 |
| Aug 19, 2024↗ | BIGAL MARCELO | Director | Buy | 1,512 | $13.25 | $20.0K | 10,142 |
| Aug 19, 2024↗ | Brege Laura | Director | Buy | 1,000 | $12.81 | $12.8K | 17,552 |
| Aug 14, 2024↗ | YANG MICHAEL J. | Director | Buy | 2,000 | $12.90 | $25.8K | 7,230 |
| Aug 13, 2024↗ | Lee Frank D. | Chief Executive Officer | Buy | 8,264 | $12.10 | $100.0K | 107,784 |
| Aug 12, 2024↗ | BIGAL MARCELO | Director | Buy | 3,400 | $12.01 | $40.8K | 8,630 |
| Aug 12, 2024↗ | Froimson Mark | Director | Buy | 1,400 | $11.58 | $16.2K | 14,473 |
| Aug 2, 2024↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 945 | $20.05 | $18.9K | 94,306.7 |
| Jul 3, 2024↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 2,836 | $28.25 | $80.1K | 95,556.7 |
| Jun 13, 2024↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 1,000 | $28.38 | $28.4K | 116,040 |
| Jun 13, 2024↗ | HASTINGS PAUL J | Director | Sell | 880 | $28.38 | $25.0K | 12,724 |
| Jun 13, 2024↗ | RIKER LAUREN | Senior Vice President, Finance | Sell | 3,970 | $28.72 | $114.0K | 38,075.3 |
| Jun 13, 2024↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 5,012 | $28.57 | $143.2K | 44,569.5 |
| Jun 13, 2024↗ | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 7,452 | $28.38 | $211.5K | 102,912 |
| Mar 8, 2024↗ | PACE GARY W | Director | Sell | 119,323 | $30.64 | $3.66M | 140,384 |
| Aug 4, 2023↗ | WINSTON ROY | Chief Medical Officer | Sell | 509 | $34.88 | $17.8K | 52,440.3 |
| Jul 7, 2023↗ | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 643 | $38.91 | $25.0K | 22,687.3 |
| Jun 16, 2023↗ | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 6,366 | $38.42 | $244.6K | 28,467 |
| Jun 16, 2023↗ | Williams Kristen Marie | Chief Administrative Officer | Sell | 6,467 | $37.03 | $239.5K | 25,375 |
| Jun 12, 2023↗ | Kronenfeld Mark A. | Director | Sell | 15,000 | $37.04 | $555.6K | 17,897 |
| Jun 7, 2023↗ | Brege Laura | Director | Sell | 600 | $38.74 | $23.2K | 9,547 |
| Jun 7, 2023↗ | Ellis Ronald J. Jr. | Chief Strategy Officer | Sell | 2,276 | $38.42 | $87.4K | 32,071 |
| Jun 7, 2023↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 3,052 | $38.52 | $117.6K | 23,591 |
| Jun 7, 2023↗ | HASTINGS PAUL J | Director | Sell | 580 | $38.34 | $22.2K | 6,599 |
| Jun 7, 2023↗ | McLoughlin Dennis | Chief Customer Officer | Sell | 2,071 | $38.42 | $79.6K | 39,172 |
| Jun 7, 2023↗ | MOLLOY ANTHONY | Chief Lgl & Compliance Officer | Sell | 6,788 | $38.46 | $261.1K | 17,398 |
| Jun 7, 2023↗ | REINHARDT MAX | President, Rest of World | Sell | 2,153 | $38.42 | $82.7K | 30,324 |
| Jun 7, 2023↗ | Reinhart Charles A. III | Chief Financial Officer | Sell | 2,607 | $38.40 | $100.1K | 34,997 |
| Jun 7, 2023↗ | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 1,207 | $38.42 | $46.4K | 19,669 |
| Jun 7, 2023↗ | SLONIN JONATHAN | Chief Clinical Officer | Sell | 961 | $38.42 | $36.9K | 36,813 |
| Jun 7, 2023↗ | STACK DAVID M | CEO and Chairman | Sell | 10,384 | $38.41 | $398.9K | 159,107 |
| Jun 7, 2023↗ | Williams Kristen Marie | Chief Administrative Officer | Sell | 2,658 | $38.42 | $102.1K | 22,249 |
| Jun 7, 2023↗ | WINSTON ROY | Chief Medical Officer | Sell | 3,636 | $38.42 | $139.7K | 43,213 |
| Jun 2, 2023↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 2,500 | $39.08 | $97.7K | 24,591 |
| May 17, 2023↗ | HASTINGS PAUL J | Director | Sell | 7,000 | $41.85 | $292.9K | 7,179 |
| May 15, 2023↗ | PACE GARY W | Director | Sell | 5,015 | $41.78 | $209.5K | 139,675 |
Showing 1–50 of 107
1 / 3
PCRX Insider Buying Activity
The following table shows recent insider purchases of Pacira BioSciences, Inc. (PCRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 19, 2024↗ | BIGAL MARCELO | Director | Buy | 1,512 | $13.25 | $20.0K | 10,142 |
| Aug 19, 2024↗ | Brege Laura | Director | Buy | 1,000 | $12.81 | $12.8K | 17,552 |
| Aug 14, 2024↗ | YANG MICHAEL J. | Director | Buy | 2,000 | $12.90 | $25.8K | 7,230 |
| Aug 13, 2024↗ | Lee Frank D. | Chief Executive Officer | Buy | 8,264 | $12.10 | $100.0K | 107,784 |
| Aug 12, 2024↗ | BIGAL MARCELO | Director | Buy | 3,400 | $12.01 | $40.8K | 8,630 |
| Aug 12, 2024↗ | Froimson Mark | Director | Buy | 1,400 | $11.58 | $16.2K | 14,473 |
PCRX Insider Selling Activity
The following table shows recent insider sales of Pacira BioSciences, Inc. (PCRX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026↗ | RIKER LAUREN | officer: Senior Vice President, Finance | Sell | 4,000 | $20.81 | $83.2K | 52,313.2 |
| Feb 3, 2026↗ | WILLIAMS KRISTEN | officer: Chief Administrative Officer | Sell | 13,137 | $20.53 | $269.7K | 131,303 |
| Jan 30, 2026↗ | Teehan Brendan | Chief Commercial Officer | Sell | 5,182 | $20.54 | $106.4K | 0 |
| Jan 30, 2026↗ | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 30,271 | $20.54 | $621.6K | 0 |
| Jan 6, 2026↗ | RIKER LAUREN | officer: Senior Vice President, Finance | Sell | 1,416 | $24.24 | $34.3K | 59,064.2 |
| Jan 2, 2026↗ | Lee Frank D. | Chief Executive Officer | Sell | 9,272 | $24.46 | $226.8K | 0 |
| Jan 2, 2026↗ | RIKER LAUREN | Senior Vice President, Finance | Sell | 1,575 | $24.26 | $38.2K | 0 |
| Dec 9, 2025↗ | Cross Shawn | Chief Financial Officer | Sell | 25,000 | $25.07 | $626.8K | 0 |
| Nov 10, 2025↗ | Cross Shawn | Chief Financial Officer | Sell | 12,060 | $22.09 | $266.4K | 0 |
| Aug 7, 2025↗ | BIGAL MARCELO | Director | Sell | 4,912 | $23.67 | $116.3K | 0 |
| Jun 3, 2025↗ | RIKER LAUREN | Senior Vice President, Finance | Sell | 8,952 | $26.28 | $235.3K | 0 |
| Jun 3, 2025↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 5,084 | $26.40 | $134.2K | 0 |
| Jan 6, 2025↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 879 | $18.40 | $16.2K | 93,443.5 |
| Dec 16, 2024↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 500 | $19.76 | $9.9K | 115,200 |
| Sep 13, 2024↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 500 | $12.86 | $6.4K | 115,700 |
| Aug 2, 2024↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 945 | $20.05 | $18.9K | 94,306.7 |
| Jul 3, 2024↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 2,836 | $28.25 | $80.1K | 95,556.7 |
| Jun 13, 2024↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 1,000 | $28.38 | $28.4K | 116,040 |
| Jun 13, 2024↗ | HASTINGS PAUL J | Director | Sell | 880 | $28.38 | $25.0K | 12,724 |
| Jun 13, 2024↗ | RIKER LAUREN | Senior Vice President, Finance | Sell | 3,970 | $28.72 | $114.0K | 38,075.3 |
| Jun 13, 2024↗ | SLONIN JONATHAN | Chief Medical Officer | Sell | 5,012 | $28.57 | $143.2K | 44,569.5 |
| Jun 13, 2024↗ | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 7,452 | $28.38 | $211.5K | 102,912 |
| Mar 8, 2024↗ | PACE GARY W | Director | Sell | 119,323 | $30.64 | $3.66M | 140,384 |
| Aug 4, 2023↗ | WINSTON ROY | Chief Medical Officer | Sell | 509 | $34.88 | $17.8K | 52,440.3 |
| Jul 7, 2023↗ | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 643 | $38.91 | $25.0K | 22,687.3 |
| Jun 16, 2023↗ | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 6,366 | $38.42 | $244.6K | 28,467 |
| Jun 16, 2023↗ | Williams Kristen Marie | Chief Administrative Officer | Sell | 6,467 | $37.03 | $239.5K | 25,375 |
| Jun 12, 2023↗ | Kronenfeld Mark A. | Director | Sell | 15,000 | $37.04 | $555.6K | 17,897 |
| Jun 7, 2023↗ | Brege Laura | Director | Sell | 600 | $38.74 | $23.2K | 9,547 |
| Jun 7, 2023↗ | Ellis Ronald J. Jr. | Chief Strategy Officer | Sell | 2,276 | $38.42 | $87.4K | 32,071 |
| Jun 7, 2023↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 3,052 | $38.52 | $117.6K | 23,591 |
| Jun 7, 2023↗ | HASTINGS PAUL J | Director | Sell | 580 | $38.34 | $22.2K | 6,599 |
| Jun 7, 2023↗ | McLoughlin Dennis | Chief Customer Officer | Sell | 2,071 | $38.42 | $79.6K | 39,172 |
| Jun 7, 2023↗ | MOLLOY ANTHONY | Chief Lgl & Compliance Officer | Sell | 6,788 | $38.46 | $261.1K | 17,398 |
| Jun 7, 2023↗ | REINHARDT MAX | President, Rest of World | Sell | 2,153 | $38.42 | $82.7K | 30,324 |
| Jun 7, 2023↗ | Reinhart Charles A. III | Chief Financial Officer | Sell | 2,607 | $38.40 | $100.1K | 34,997 |
| Jun 7, 2023↗ | Riker Lauren Bullaro | Senior Vice President, Finance | Sell | 1,207 | $38.42 | $46.4K | 19,669 |
| Jun 7, 2023↗ | SLONIN JONATHAN | Chief Clinical Officer | Sell | 961 | $38.42 | $36.9K | 36,813 |
| Jun 7, 2023↗ | STACK DAVID M | CEO and Chairman | Sell | 10,384 | $38.41 | $398.9K | 159,107 |
| Jun 7, 2023↗ | Williams Kristen Marie | Chief Administrative Officer | Sell | 2,658 | $38.42 | $102.1K | 22,249 |
| Jun 7, 2023↗ | WINSTON ROY | Chief Medical Officer | Sell | 3,636 | $38.42 | $139.7K | 43,213 |
| Jun 2, 2023↗ | GAUGLER DARYL | Chief Operating Officer | Sell | 2,500 | $39.08 | $97.7K | 24,591 |
| May 17, 2023↗ | HASTINGS PAUL J | Director | Sell | 7,000 | $41.85 | $292.9K | 7,179 |
| May 15, 2023↗ | PACE GARY W | Director | Sell | 5,015 | $41.78 | $209.5K | 139,675 |
PCRX Insiders
Similar Stocks to PCRX
ZTS
Zoetis Inc.
$115.50+0.03%
$50.88B
TEVA
Teva Pharmaceutical Industries Limited
$28.41-3.04%
$36.69B
VTRS
Viatris Inc.
$13.51-1.99%
$15.56B
NBIX
Neurocrine Biosciences, Inc.
$129.78+1.29%
$13.03B
INDV
Indivior Pharmaceuticals Inc
$31.32+1.49%
$4.05B
SUPN
Supernus Pharmaceuticals, Inc.
$49.80-1.30%
$3.08B
PAHC
Phibro Animal Health Corporation
$49.52+1.06%
$1.95B
ANIP
ANI Pharmaceuticals, Inc.
$70.32-3.00%
$1.68B